tDCS Plus Physical Therapy for Progressive Supranuclear Palsy

Sponsor
Fondazione Europea di Ricerca Biomedica Ferb Onlus (Other)
Overall Status
Completed
CT.gov ID
NCT04237948
Collaborator
Università degli Studi di Brescia (Other), University of Kiel (Other)
20
1
2
23.4
0.9

Study Details

Study Description

Brief Summary

Objective of the study:

To test the efficacy of cerebellar transcranial direct current stimulation (tDCS) associated with physical rehabilitation on postural instability and falls in progressive supranuclear palsy using a double-blind design and wearing sensors technology

Design:

Twenty probable PSP patients with no dementia and still able to walk will be recruited for a randomized double-blind sham-controlled study. Each patient will be hospitalized for a four week physical rehabilitation. In the real-arm, the patients will undergo a ten cerebellar tDCS stimulations while the placebo arm will undergo sham stimulation.

Each patient will be evaluated before and after stimulation by PSP-rating scale (PSP-RS), cognitive tests and a battery of gait and movement tests using wearing sensors technology.

Condition or Disease Intervention/Treatment Phase
  • Device: transcranial direct current stimulation (tDCS)
  • Behavioral: Physical therapy
N/A

Detailed Description

Background:

There are no medical effective treatments for progressive supranuclear palsy (PSP). Imaging, neurophysiology and pathology studies suggested cerebellum as possible target of brain stimulation for postural instability using tDCS stimulation

Objective of the study:

To test the efficacy of cerebellar transcranial direct current stimulation (tDCS) associated with physical rehabilitation on postural instability and falls in progressive supranuclear palsy using a double-blind design and wearing sensors technology

Design:

Twenty probable PSP patients with no dementia and still able to walk will be recruited for a randomized double-blind sham-controlled study. Each patient will be hospitalized for a four week physical rehabilitation. In the real-arm, the patients will undergo a 10 days cerebellar tDCS stimulation while the placebo arm will undergo sham stimulation.

cerebellar tDCS consists in the application of a low intensity (1-2 mA) steady current through a surface scalp electrode over the cerebellum for ten days.

Each patient will be evaluated before and after stimulation by berg balance tests (BBS), Tinetti scale, PSP-rating scale (PSP-RS), cognitive assessment and a battery of gait and movement tests using wearing sensors technology.

Sensors assessment:

The following parameters will be evaluated before and after stimulation (real vs sham): The parameter for postural instability defined are:

  1. TIME, defined as time without falling ii) The parameter "surface", defined as the sway area iii) Velocity describes the mean velocity of the compensatory movements given in mm/s.
  2. Acceleration described as root mean square (RMS), v) Jerk, the time derivate of acceleration, quantifies smoothness of the compensatory movements given in mG/s.

The parameter for gait and turning evaluation during normal walk and timed up and go, defined are: i) stealth length ii) step variability iii) step phases duration iv) gait speed v) turning velocity

Study Design

Study Type:
Interventional
Actual Enrollment :
20 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Two randomized double blind groups will be evaluated. Both group will undergo physical rehabilitation. The real arm group will undergo real cerebellar tDCS while the placebo-arm will undergo a sham stimulationTwo randomized double blind groups will be evaluated. Both group will undergo physical rehabilitation. The real arm group will undergo real cerebellar tDCS while the placebo-arm will undergo a sham stimulation
Masking:
Double (Participant, Investigator)
Masking Description:
The patient and the examiner who did the ratings were blind to the type of tDCS delivered, which was applied by another blinded experimenter.
Primary Purpose:
Treatment
Official Title:
tDCS Plus Physical Therapy for Progressive Supranuclear Palsy: a Double Blind Randomized Sham-controlled Study With Wearing Sensors Technology
Actual Study Start Date :
Jan 1, 2018
Actual Primary Completion Date :
Nov 15, 2019
Actual Study Completion Date :
Dec 15, 2019

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: physical therapy plus REAL tDCS

Patients will be undergo a rehabilitation treatment during hospitalization consisting in 60 minutes of physical rehabilitation for 4 weeks. Real Cerebellar tDCS will be applied for 10 days of time.

Device: transcranial direct current stimulation (tDCS)
cerebellar tDCS consists in the application of a low intensity (1-2 mA) steady current through a surface scalp electrode over the cerebellum

Behavioral: Physical therapy
Hospitalized patients will undergo a 60 minutes physical treatment improving gait and postural instability for four weeks of time

Placebo Comparator: physical therapy plus SHAM tDCS

Patients will be undergo a rehabilitation treatment during hospitalization consisting in 60 minutes of physical rehabilitation for 4 weeks. Sham Cerebellar tDCS will be applied for 10 days of time.

Behavioral: Physical therapy
Hospitalized patients will undergo a 60 minutes physical treatment improving gait and postural instability for four weeks of time

Outcome Measures

Primary Outcome Measures

  1. PSP rating scale (PSP-RS) [Changes from Baseline to immediately after stimulation and after 3 months]

    Assessment of postural instability and disability of patients (scores ranging from 0 to 100, lower scores indicate less disability)

  2. Falls [Number of falls recorded starting from immediately after stimulation until 3 months after the end of stimulation]

    Number of falls will be recorded using a diary

  3. Cognitive testing [Changes from Baseline to immediately after stimulation]

    Total Z-scores of cognitive assessment (including eight tests assessing memory, executive function, attention and visual-spatial function)

  4. Static Balance- area of sway [Changes from Baseline to immediately after stimulation]

    The area of sway during the postural instability tasks will be assessed (unit of measure mm2)

Secondary Outcome Measures

  1. Tinetti Balance test (TBT) [Changes from Baseline to immediately after stimulation and after 3 months]

    Assessment of postural instability (0-28, higher scores indicate better performances)

  2. Static Balance: wearable sensor analyses - velocity [Changes from Baseline to immediately after stimulation]

    the velocity of sway will be assessed during the postural instability tasks (unit of measure (mm/s)

  3. Gait speed [Changes from Baseline to immediately after stimulation]

    The speed of gait will be assessed in one minute of normal and dual-task walking

  4. Turning speed [Changes from Baseline to immediately after stimulation]

    The velocity of turning will be assessed in timed up and go tests

  5. Activity of daily living [Changes from Baseline to immediately after stimulation]

    the dependence of patient in ADL will be assessed with the help of caregiver

Eligibility Criteria

Criteria

Ages Eligible for Study:
40 Years to 85 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:

probable PSP diagnosis ability to stand alone without support for at least 5 seconds ability to walk without aid for at least three meters

Exclusion Criteria:

dementia or behavioral alterations contraindications of stimulation

Contacts and Locations

Locations

Site City State Country Postal Code
1 Parkinson's disease Rehabilitation Centre - FERB ONLUS Trescore Balneario Italy

Sponsors and Collaborators

  • Fondazione Europea di Ricerca Biomedica Ferb Onlus
  • Università degli Studi di Brescia
  • University of Kiel

Investigators

  • Principal Investigator: Andrea Pilotto, MD, FERB onlus

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Andrea Pilotto, Parkinson's disease Rehabilitation Centre, Fondazione Europea di Ricerca Biomedica Ferb Onlus
ClinicalTrials.gov Identifier:
NCT04237948
Other Study ID Numbers:
  • 19/02
First Posted:
Jan 23, 2020
Last Update Posted:
Jan 23, 2020
Last Verified:
Jan 1, 2020
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Andrea Pilotto, Parkinson's disease Rehabilitation Centre, Fondazione Europea di Ricerca Biomedica Ferb Onlus
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 23, 2020